PAREA launches policy brief in the EP on how the EU Biotech Act could bring treatments to people living with mental health conditions
16:07 by Tadeusz HAWROT (Psychedelic Access and Research European Alliance - PAREA)The brief sets out four priorities: target unmet needs, connect trial centres across Europe, attract long-term investment and back public-led trials to repurpose medicines where commercial incentives are weak: https://tinyurl.com/brief-act